Safety and Efficacy of PolyHeme(R) in Hemorrhagic Shock Following Traumatic Injuries Beginning in the Pre-Hospital Setting
- Conditions
- Hemorrhagic Shock
- Registration Number
- NCT00076648
- Lead Sponsor
- Northfield Laboratories
- Brief Summary
This study is designed to assess the survival benefit of administering PolyHeme to severely injured trauma patients in hemorrhagic shock beginning in the prehospital setting, where blood is not available, and continuing throughout a 12-hour postinjury hospital setting.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- Not specified
- Adult patients following trauma who have sustained blood loss and are in shock
- Patients who have sustained unsurvivable injuries
- Patients who have severe head injury
- Pregnant females
- Patients found in cardiac arrest
- Patients who object to participation (e.g., religious grounds, wearing exclusion bracelet).
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (32)
Scripps Mercy
🇺🇸San Diego, California, United States
UC San Diego Medical Center
🇺🇸San Diego, California, United States
Denver Health Medical Center
🇺🇸Denver, Colorado, United States
Christiana Hospital
🇺🇸Newark, Delaware, United States
Medical Center of Central Georgia
🇺🇸Macon, Georgia, United States
Loyola University Medical Center
🇺🇸Maywood, Illinois, United States
Methodist Hospital of Indiana
🇺🇸Indianapolis, Indiana, United States
Wishard Memorial Hospital
🇺🇸Indianapolis, Indiana, United States
University of Kansas Medical Center
🇺🇸Kansas City, Kansas, United States
University of Kentucky Medical Center
🇺🇸Lexington, Kentucky, United States
Scroll for more (22 remaining)Scripps Mercy🇺🇸San Diego, California, United States